The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 115-120

  Ogawa, Eiichi ^a   Hosokawa, Masaya ^a,b   Harada, Norio ^a   Yamane, Shunsuke ^a   Hamasaki, Akihiro ^a   Toyoda, Kentaro ^a   Fujimoto, Shimpei ^a   Fujita, Yoshihito ^a   Fukuda, Kazuhito ^a   Tsukiyama, Katsushi ^a,c   Yamada, Yuichiro ^a,c   Seino, Yutaka ^a,d   Inagaki, Nobuya ^a,e  

^a KYOTO UNIVERSITY   (Japan)

^b Tezukayama Gakuin University   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANSAI ELECTRIC POWER CO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

GIP; Glucose absorption; Intestine

Indexed keywords

CYCLOSOMATOSTATIN; GASTRIC INHIBITORY POLYPEPTIDE; SODIUM GLUCOSE COTRANSPORTER; SOMATOSTATIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL TRANSIT; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE MOTILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; WILD TYPE;

ANIMALS; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL MOTILITY; GLUCOSE; INTESTINAL ABSORPTION; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PERFUSION; RECEPTORS, GLUCAGON; SOMATOSTATIN;

MUS;

EID: 78650913178     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.077     Document Type: Article

References (29)

1. Seino Y., Fukushima M., Yabe D. GIP and GLP-1, the two incretin hormones: similarities and differences. J. Diabetes Invest. 2010, 1:8-23.
2. Miyawaki K., Yamada Y., Yano H H., et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999, 96:14843-14847.
3. Usdin T.B., Mezey E., Button D.C., et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 1993, 133:2861-2870.
4. Sababi M., Bengtsson U.H. Enhanced intestinal motility influences absorption in anaesthetized rat. Acta Physiol. Scand. 2001, 172:115-122.
5. Smout A.J. Small intestinal motility. Curr. Opin. Gastroenterol. 2004, 20:77-81.
6. Scrocchi L.A., Brown T.J., MaClusky N., et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 1996, 2:1254-1258.
7. -/- mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282:G634-639.
8. Tsukiyama K., Yamada Y., Miyawaki K., et al. Gastric inhibitory polypeptide is the major insulinotropic factor in K(ATP) null mice. Eur. J. Endocrinol. 2004, 151:407-412.
9. Yamada K., Hosokawa M., Fujimoto S., et al. The spontaneously diabetic Torii rat with gastroenteropathy. Diabetes Res. Clin. Pract. 2007, 75:127-134.
10. +/glucose co-transporter. Nature 1987, 330:379-381.
11. Singh S.K., Bartoo A.C., Krishnan S., et al. Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport. Obesity 2008, 16:2412-2416.
12. Wilson F.A., Dietschy J.M. The intestinal unstirred layer: its surface area and effect on active transport kinetics. Biochim. Biophys. Acta 1974, 363:112-126.
13. Rayner D.V. The relationships between glucose absorption and insulin secretion and the migrating myoelectric complex in the pig. Exp. Physiol. 1991, 76:67-76.
14. Wettergren A., Schjoldager B., Mortensen P.E., et al. Truncated GLP-1 (proglucagon 78-107-amido) inhibits gastric and pancreatic functions in man. Dig. Dis. Sci. 1993, 38:665-673.
15. Miki T., Minami K., Shinozaki H., et al. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 2005, 54:1956-1963.
16. Lin H.C., Elashoff J.D., Kwok G.M., et al. Stimulation of duodenal motility by hyperosmolar mannitol depends on local osmoreceptor control. Am. J. Physiol. 1994, 266:G940-943.
17. Mazzaferri E.L., Ciofalo L., Waters L.A., et al. Effects of gastric inhibitory polypeptide on leucine- and arginine-stimulated insulin release. Am. J. Physiol. 1983, 245:E114-E120.
18. Vilsbøll T., Krarup T., Madsbad S., et al. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia 2002, 45:1111-1119.
19. Lamont B.J., Drucker D.J. Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice. Diabetes 2008, 57:190-198.
20. Szecówka J., Grill V., Sandberg E., et al. Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. Acta Endocrinol. (Copenh) 1982, 99:416-421.
21. Hansen L., Holst J.J. The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno-ileal loop?. Regul. Pept. 2002, 110:39-45.
22. Holst J.J., Jensen S.L., Knuhtsen S., et al. Effect of vagus, gastric inhibitory polypeptide, and HCl on gastrin and somatostatin release from perfused pig antrum. Am. J. Physiol. 1983, 244:G515-522.
23. Krejs G.J. Effect of somatostatin and absorption and atropine infusion on intestinal transit tine and fructose absorption in the perfused human jejunum. Diabetes 1984, 33:548-551.
24. Johansson C., Wisén O., Efendić S., et al. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 1981, 22:126-137.
25. Krempels K., Hunyady B., O'Carroll A.M., et al. Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract. Gastroenterology 1997, 112:1948-1960.
26. Gugger M., Waser B., Kappeler A., et al. Cellular detection of sst2A receptors in human gastrointestinal tissue. Gut 2004, 53:1431-1436.
27. Sternini C., Wong H., Wu S.V., et al. Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract. J. Comp. Neurol. 1997, 386:396-408.
28. Wahren J. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 1976, 2:1213-1216.
29. Féry F., Tappy L., Schneiter P., et al. Effect of somatostatin on duodenal glucose absorption in man. J. Clin. Endocrinol. Metab. 2005, 90:4163-4169.